1. Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya
- Author
-
M.A. van de Ree, J. B. O. Were, M. Keuter, W. A. Ngwawe, A. D. Brandling-Bennett, M. Raasveld, William M. Watkins, A. van Eijk, and M. Hoogstrate
- Subjects
Adult ,medicine.medical_specialty ,Adolescent ,Proguanil ,Sulfadoxine ,medicine.medical_treatment ,Plasmodium falciparum ,Chlorproguanil ,Reproductive age ,Dapsone ,Pharmacology ,Antimalarials ,chemistry.chemical_compound ,Pregnancy ,Chloroquine ,medicine ,Animals ,Humans ,Prospective Studies ,Pregnancy Complications, Infectious ,General Environmental Science ,biology ,business.industry ,Obstetrics ,General Engineering ,Obstetrics and Gynecology ,General Medicine ,medicine.disease ,biology.organism_classification ,Non pregnant ,Malaria ,Pyrimethamine ,chemistry ,General Earth and Planetary Sciences ,Drug Therapy, Combination ,Female ,business ,Research Article ,medicine.drug - Abstract
OBJECTIVE--To compare treatment and protection against falciparum malaria in pregnant and non-pregnant women with three drug regimens. DESIGN--Prospective intervention study with six weeks' follow up. Patients received one of three drug regimens in order of entry. SETTING--Primary care hospital and secondary girls' school in rural western Kenya. PATIENTS--158 of 988 pregnant women (89 primigravid and 69 multigravid) in the third trimester and 105 of 1488 non-pregnant schoolgirls of reproductive age were parasitaemic (more than 500 asexual forms/microliter. These women were divided into three treatment groups by gravid state. INTERVENTIONS--Women were treated with chloroquine base 25 mg/kg over three days or pyrimethamine 75 mg and sulfadoxine 1500 mg as a single dose or chlorproguanil 1.2 mg/kg and dapsone 2.4 mg/kg as a single dose. MAIN OUTCOME MEASURES--Parasitaemia and haemoglobin concentrations measured at seven day intervals for six weeks. RESULTS--Primigravid women were more likely to be parasitaemic on follow up than multigravidas or nulligravidas, whose response was about the same. Parasites did not clear by day 7 in primigravidas in six (20%) of 30 who received chloroquine, three (8%) of 35 treated with pyrimethamine and sulfadoxine, and none of 23 treated with chlorproguanil and dapsone. At day 28, 83%, 19%, and 67% of primigravidas in these treatment groups were parasitaemic. Haemoglobin concentrations rose in all women, but improvement was sustained only in women who remained free of parasites. CONCLUSIONS--Clearance of parasites was better with either pyrimethamine and sulfadoxine or chlorproguanil and dapsone than with chloroquine. Longest protection was obtained with pyrimethamine and sulfadoxine.
- Published
- 1990
- Full Text
- View/download PDF